BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31812628)

  • 1. Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents.
    Gurjar AA; Kushwaha S; Chattopadhyay S; Das N; Pal S; China SP; Kumar H; Trivedi AK; Guha R; Chattopadhyay N; Sanyal S
    Metabolism; 2020 Feb; 103():154044. PubMed ID: 31812628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy.
    Hong Y; Lee JH; Jeong KW; Choi CS; Jun HS
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):903-918. PubMed ID: 31020810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 impairs skeletal muscle myogenesis and development via ETB receptors and p38 MAPK signaling pathway.
    Liu SY; Chen LK; Jhong YT; Chen CW; Hsiao LE; Ku HC; Lee PH; Hwang GS; Juan CC
    Clin Sci (Lond); 2024 Jun; 138(12):711-723. PubMed ID: 38804865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Cellular Pharmacological Approach to the Development of Drugs to Treat Muscle Wasting].
    Sakamoto K
    Yakugaku Zasshi; 2018; 138(10):1271-1275. PubMed ID: 30270271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
    Wu X; Li S; Xue P; Li Y
    Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loquat leaf extract enhances myogenic differentiation, improves muscle function and attenuates muscle loss in aged rats.
    Sung B; Hwang SY; Kim MJ; Kim M; Jeong JW; Kim CM; Chung HY; Kim ND
    Int J Mol Med; 2015 Sep; 36(3):792-800. PubMed ID: 26178971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bakuchiol augments MyoD activation leading to enhanced myoblast differentiation.
    Lee SJ; Yoo M; Go GY; Kim DH; Choi H; Leem YE; Kim YK; Seo DW; Ryu JH; Kang JS; Bae GU
    Chem Biol Interact; 2016 Mar; 248():60-7. PubMed ID: 26902638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic drug liraglutide alleviates low muscle mass by inhibiting the expression of MuRF1 and MAFbx in diabetic muscle atrophy.
    Fan D; Wang Y; Liu B; Yin F
    J Chin Med Assoc; 2023 Feb; 86(2):166-175. PubMed ID: 36279106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z-ajoene from Crushed Garlic Alleviates Cancer-Induced Skeletal Muscle Atrophy.
    Lee H; Heo JW; Kim AR; Kweon M; Nam S; Lim JS; Sung MK; Kim SE; Ryu JH
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule adiponectin receptor agonist GTDF protects against skeletal muscle atrophy.
    Singh AK; Shree S; Chattopadhyay S; Kumar S; Gurjar A; Kushwaha S; Kumar H; Trivedi AK; Chattopadhyay N; Maurya R; Ramachandran R; Sanyal S
    Mol Cell Endocrinol; 2017 Jan; 439():273-285. PubMed ID: 27645900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells.
    Li Z; Ni CL; Yao Z; Chen LM; Niu WY
    Metabolism; 2014 Aug; 63(8):1022-30. PubMed ID: 24972503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinospora cordifolia protects from skeletal muscle atrophy by alleviating oxidative stress and inflammation induced by sciatic denervation.
    Sharma B; Dutt V; Kaur N; Mittal A; Dabur R
    J Ethnopharmacol; 2020 May; 254():112720. PubMed ID: 32114167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice.
    Iwai S; Kaji K; Nishimura N; Kubo T; Tomooka F; Shibamoto A; Suzuki J; Tsuji Y; Fujinaga Y; Kitagawa K; Namisaki T; Akahane T; Yoshiji H
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166770. PubMed ID: 37276988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vitro model for the assessment of postnatal myonuclear accretion.
    Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
    Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.
    Xiang J; Qin L; Zhong J; Xia N; Liang Y
    Diabetes Metab Syndr Obes; 2023; 16():2433-2446. PubMed ID: 37602204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D/Vitamin D Receptor Signaling Attenuates Skeletal Muscle Atrophy by Suppressing Renin-Angiotensin System.
    Li WX; Qin XH; Poon CC; Wong MS; Feng R; Wang J; Lin FH; Sun YL; Liu SF; Wang YJ; Zhang Y
    J Bone Miner Res; 2022 Jan; 37(1):121-136. PubMed ID: 34490953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal Muscle Atrophy.
    Shirakawa T; Miyawaki A; Matsubara T; Okumura N; Okamoto H; Nakai N; Rojasawasthien T; Morikawa K; Inoue A; Goto A; Washio A; Tsujisawa T; Kawamoto T; Kokabu S
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33050588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.